STX — Shield Therapeutics Share News
0.000.00%
Last trade - 00:00- £11.93m
- £4.10m
- £5.49m
- 24
- 45
- 17
- 17
REG - Shield Therapeutics - Unaudited Full Year Trading Update
AnnouncementREG - Shield Therapeutics - Appointment of new Chief Financial Officer
AnnouncementREG - Shield Therapeutics - Q3 2023 U.S. Commercial Highlights
AnnouncementREG - Shield Therapeutics - PDMR Transaction Notification
AnnouncementRCS - Shield Therapeutics - Abstract to be presented at Healthcare Conference
AnnouncementREG - Shield Therapeutics - Chief Financial Officer Transition
AnnouncementREG - Shield Therapeutics - Result of REX Retail Offer
AnnouncementREG - Shield Therapeutics - Completion of SWK Financing
AnnouncementREG - Shield Therapeutics - Block listing Interim Return
AnnouncementREG - Cavendish Financial - AGM Trading Statement
AnnouncementREG - Shield Therapeutics - Successful completion of US$6.1m Equity Fundraise
AnnouncementREG - Shield Therapeutics - $20m secured debt facility &proposed equity raise
AnnouncementREG - Shield Therapeutics - REX Retail Offer
AnnouncementREG - Shield Therapeutics - Interim results update and business update
AnnouncementREG - Shield Therapeutics - Notice of Results and Change in reporting currency
AnnouncementREG - Shield Therapeutics Jupiter Fund Mgmt - Holding(s) in Company
AnnouncementREG - Shield Therapeutics - Business Update and U.S. Q2 2023 Highlights
AnnouncementREG - Shield Therapeutics - Results of 2023 Annual General Meeting
AnnouncementREG - Peel Hunt LLP Shield Therapeutics - Form 8.5 (EPT/RI) - Shield Therapeutics Plc
Announcement